undamentalytics Newsletter
Sign in

Inmed Pharmaceuticals Inc. balance sheet

At the end of fiscal 2025, Inmed Pharmaceuticals Inc. had total assets of $15.6m, total liabilities of $2.1m and shareholders' equity of $13.4m. It held $10.7m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 2025LTMDec 2025
Cash and equivalents7697117
Receivables000000
Inventory—22111
Total current assets810119139
Total assets101314121611
Accounts payable———0——
Total current liabilities232221
Total debt000000
Total liabilities242322
Shareholders' equity791291310
Shares outstanding—————3m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ENSC vs INMINM vs OCGNINM vs TRDA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Inmed Pharmaceuticals Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inmed Pharmaceuticals Inc.